Trial NCT03272217

View at ClinicalTrials.gov 
Aliases: NCT03133390
Org. Study IDs: HCRN GU15-215

Last trial update was posted on 2022-12-19

MeSH Interventions

Atezolizumab Bevacizumab

MeSH Conditions

Carcinoma, Transitional Cell

Other Conditions

Urothelial Carcinoma

Stopping Reasons

Funder decision

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID